Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 27, 2026 08:00AM
Jan 27, 2026 08:00AM
Dec 10, 2025 08:03AM
Dec 10, 2025 08:00AM
Nov 19, 2025 09:46AM Nuclear Power Surge, $10M Buyback, and a $1.9B SEO Bombshell
Nov 18, 2025 04:15PM
Nov 18, 2025 04:15PM
Oct 28, 2025 06:43AM
Oct 27, 2025 07:16AM
Oct 27, 2025 07:15AM
Oct 7, 2025 08:33AM
Oct 7, 2025 08:30AM Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
Oct 2, 2025 08:31AM
Oct 2, 2025 08:30AM
Oct 1, 2025 09:21AM
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM
Jul 9, 2025 08:00AM
Jul 9, 2025 08:00AM Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase
Jun 11, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 5, 2025 08:00AM
May 15, 2025 08:00AM
Mar 31, 2025 07:31AM
Mar 31, 2025 07:30AM
Feb 20, 2025 08:46AM Kazia Therapeutics (KZIA) and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation
Feb 20, 2025 08:46AM
Jan 30, 2025 07:31AM
Jan 30, 2025 07:30AM
Jan 14, 2025 04:00PM
Jan 10, 2025 10:01AM
Jan 10, 2025 09:58AM
Dec 31, 2024 08:00AM Kazia Therapeutics (KZIA) Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Dec 31, 2024 08:00AM
Dec 11, 2024 08:00AM
Nov 4, 2024 07:31AM
Nov 4, 2024 07:30AM
Oct 2, 2024 08:47AM
Oct 2, 2024 08:45AM
Sep 23, 2024 08:30AM Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium
Sep 12, 2024 07:30AM
Sep 12, 2024 07:30AM
Jul 10, 2024 07:30AM
Jul 10, 2024 07:30AM
Jul 10, 2024 07:30AM
Jun 27, 2024 08:15AM
May 23, 2024 02:41PM Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
May 1, 2024 08:46AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All